23andMe and GSK are mining customers’ DNA data in a hunt for new drugs
July 23, 2019 at 07:51 AM EDT
Genetic test-kit company 23andMe Inc. has for years used saliva to tell millions of consumers how closely related they are to Neanderthals or whether they are likely to develop diseases like diabetes or Alzheimer’s. Now, it’s fulfilling a bigger ambition: drug development.